Skip to main content

Table 1 Overview of the patients included in this study. “n=” Indicates the number of patients. FX = fractions; GTV = Gross Tumor Volume, PTV = Planning Target Volume, OAR = Organ at Risk

From: Treatment plan quality during online adaptive re-planning

Treatment Number of treatments Fractionation Treatment technique Total number of FX Optimization method GTV median
[range] (cm3)
PTV median
[range] (cm3)
OAR
Planned Delivered Full Weight  
Abdomen 18    84 81 52 (64%) 29 (36%)    
 Pancreas 3 5*6.6 Gy (n = 2)
5*8.0 Gy (n = 1)
SBRT (n = 3) 15 15 13 2 16.1 [1.4–53.9] 45.5 [8.7–78.8] Duodenum (n = 1)
Bowel (n = 1)
Stomach (n = 1)
 Kidney 2a 5*6.0 Gy (n = 1)
5*8.0 Gy (n = 1)
SBRT (n = 2) 9 9 5 4 14.1 [2.1–26.0] 37.5 [8.4–66.6] Bowel (n = 1)
 Adrenal gland 5 5*6.0 Gy (n = 3)
5*7.0 Gy (n = 2)
SBRT (n = 5) 25 22d 10 12 20.7 [11.2–30.2] 59.8 [33.2–105.7] Duodenum (n = 2)
Bowel (n = 3)
 Abdomen, other 8 2*5.0 Gy (n = 1)
3*3.0 Gy (n = 1)
5*6.0 Gy (n = 2)
5*6.6 Gy (n = 1)
5*7.0 Gy (n = 1)
5*8.0 Gy (n = 1)
5*9.0 Gy (n = 1)
non-SBRT (n = 1)
SBRT (n = 7)
35 35 24 11 8.7 [2.2–58.9] 27.8 [10.6–92.2] Duodenum (n = 1)
Bowel (n = 3)
Stomach (n = 3)
Prostate 13    55 55 32 (58%) 22 (40%)    
 Prostate SBRT 8 1*5.0 Gy (n = 1)
5*7.0 Gy (n = 1)
5*7.25 Gy (n = 6)
SBRT (n = 8) 36 36 27 9 29.2 [1.9–50.5] 29.2 [11.8–86.2] Rectum (n = 8)
Bladder (n = 8)
 Prostate IMRT 5 3*2.0 Gy (n = 3)
4*2.0 Gy (n = 1)
6*2.0 Gy (n = 1)
non-SBRT (n = 5) 19 19 5 13 1.8 [0.77–3.3] 11.3 [5.7–12.1] Rectum (n = 5)
Bladder (n = 5)
Lung 10b 3*10 Gy (n = 1)
3*12.5 Gy (n = 3)
5*8.0 Gy (n = 1)
5*9.0 Gy (n = 3)
8*6.0 Gy (n = 2)
SBRT (n = 10) 48 48 28 (58%) 13 (27%) 4.1 [0.54–67.6] 17.1 [4.6–131.3]  
Liver 9    38 38 31 (82%) 7 (18%)    
 Liver SBRT 5a 5*6.0 Gy (n = 1)
5*9.0 Gy (n = 3)
6*5.0 Gy (n = 1)
SBRT (n = 5) 26 26 21 5 25.5 [6.8–122.2] 67.4 [37.0–292.2] Bowel (n = 1)
 Liver IMRT 4 3*3.0 Gy (n = 4) non-SBRT (n = 4) 12 12 10 2 20.2 [10.9–27.8] 75.7 [46.8–100.3] Duodenum (n = 4)
Pelvis 5c 5*6.5 Gy (n = 1)
5*7.0 Gy (n = 4)
SBRT (n = 5) 25 25 10 (40%) 14 (56%) 4.3 [0.32–5.4] 12.7 [2.5–19.3] Bowel (n = 2)
  1. aOne patient had two lesions: kidney and liver
  2. bOne patient had two lung lesions
  3. cOne patient had two pelvis lesions
  4. dPatient continued treatment on conventional linac